Mobile

A multi-center, randomized, open-label, controlled, one-year trial to measure the effect of zoledronic acid and alendronate on bone metabolism in post menopausal women with osteopenia and osteoporosis

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-001703-11

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To prove superiority of zoledronic acid compared to alendronate by testing the hypothesis that the change of the level of NTx in serum within the first 12 months after start of therapy in postmenopausal women is higher.

Critère d'inclusion

  • osteopenia/osteoporosis in postmenopausal women

Liens